Table 1 |
|||||
|
The antibodies used in the study |
|||||
|
Antibodies |
Source |
Antibody |
HIER |
Dilution |
Staining interpretation |
|
|
|||||
|
Vimentin |
DakoCytomation |
Mo V9 |
2 |
1:50 |
Cytoplasmic |
|
Cytokeratin |
DakoCytomation |
Mo AE1/AE3 |
1 |
1: 50 |
Cytoplasmic |
|
S100 |
DakoCytomation |
Rabbit polyclonal |
1 |
1: 500 |
Cytoplasmic +/-nuclear |
|
Desmin |
DakoCytomation |
Mo D33 |
2 |
prediluted |
Cytoplasmic |
|
SMA |
DakoCytomation |
Mo 1A4 |
2 |
1:50 |
Cytopmasmic |
|
CD34 |
Biogenex |
Mo QBEnd 10 |
2 |
Prediluted |
Membranous |
|
CD10 |
Novocastra |
NCL-CD10-270 |
1 |
1:50 |
Membranous |
|
|
|||||
|
Mo: mouse monoclonal. 1-Tris-EDTA pH9.0. 2-Citrate buffer pH6.0. |
|||||
|
Abd El All Diagnostic Pathology 2006 1:13 doi:10.1186/1746-1596-1-13 |
|||||